(Q48623345)

13 February 2018

title

Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. (English)

1 reference

13 February 2018

author name string

I Maurer

series ordinal

1

1 reference

13 February 2018

H J Möller

series ordinal

2

1 reference

13 February 2018

publication date

1 September 1997

1 reference

13 February 2018

Molecular and Cellular Biochemistry

published in

1 reference

13 February 2018

volume

174

1 reference

13 February 2018

issue

1-2

1 reference

13 February 2018

page(s)

255-259

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1006872911332

exact match

0 references

cites work

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

1 reference

12 December 2020

Mitochondrial genetics: a paradigm for aging and degenerative diseases?

1 reference

12 December 2020

The accumulation of S35-chlorpromazine in brain.

1 reference

12 December 2020

The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography

1 reference

12 December 2020

Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats

1 reference

12 December 2020

Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain

1 reference

12 December 2020

Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

1 reference

12 December 2020

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

12 December 2020

Accumulation in vitro of 35 S-chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus

1 reference

12 December 2020

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

1 reference

12 December 2020

Blood to brain distribution of neuroleptics

1 reference

12 December 2020

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

12 December 2020

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

12 December 2020

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

1 reference

12 December 2020

Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases

1 reference

12 December 2020

Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man

1 reference

12 December 2020

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

1 reference

12 December 2020

Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age

1 reference

12 December 2020

Neuroleptic medications inhibit complex I of the electron transport chain

1 reference

12 December 2020

Serotonergic involvement with neuroleptic catalepsy

1 reference

12 December 2020

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

12 December 2020

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006872911332

1 reference

13 February 2018

Dimensions Publication ID

1028281647

0 references

1 reference

13 February 2018